1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INHIBIKASE THERAPEUTICS INC
Inhibikase Therapeutics Inc XNAS: IKT

Inhibikase Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinas...

Read More
1.62 0.08 (5.19%)
61.43% Fall from 52W High
26,972
XNAS Volume

XNAS 11 Sep, 2025 1:04 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
11.3 / 100
Momentum Score
Technically Bearish
28.7 / 100
Analyst Price Target
No estimates available

8

S

11

W

4

O

1

T

SWOT Analysis

Inhibikase Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..